|
|
|
|
| Special Feature |
 |
|
Pharm Exec's Top 50 Pharma Companies 2017 |
Pharm Exec's 17th annual listing of the top biopharma players paints a stable picture of performance for the usual placeholders, but change and disruption to current business models could upend positioning in the years ahead
... /Read more/ |
|
|
|
| Calendar |
|
/ August 8–9: Bio/Pharma Strategic Portfolio Management Summit / |
|
Cambridge, MA |
|
/ August 14–16: 11th Annual Forum on Transparency & Aggregate Spend / |
|
Washington, DC |
|
/ August 16–17: Reimbursement and Access / |
|
Philadelphia, PA |
|
/ August 21–22: Bio/Pharma Forum on Data Science
/ |
|
Philadelphia, PA |
|
/ September 14-15, 2017: Compliance Congress for Specialty Products
/ |
|
Boston, MA |
|
/ September 14–15: Risk Based Global Monitoring 2017
/ |
|
Barcelona, Spain |
|
/ October 24–25: 12th Annual Value-Based Oncology Management
/ |
|
Scottsdale, AZ |
|
/ December 12–13: Patient Journey Mapping: From Diagnosis to Treatment / |
|
Philadelphia, PA |
|
/ February 27–28, 2018: Speaker Programs 2018
/ |
|
Philadelphia, PA |
|
|
|
| Industry update |
| //Verona Pharma (London, UK) appointed Desiree Luthman to the company's executive team as Vice President, Regulatory Affairs. //Kymab (Cambridge, UK) appointed Dr. Sonia Quaratino as Chief Medical Officer. //ThromboGenics (Leuven, Belgium) appointed long-time non-executive director Thomas Clay as its next Chairman. The appointment coincided with the retirement of ThromboGenics' Chairman of the Board, Staf Van Reet, Ph.D. //Adherium Limited (Melbourne, Australia) named Arik Anderson as Group Chief Executive Officer (CEO). //
Nabriva Therapeutics (Dublin, Ireland, and King of Prussia, PA) announced the appointment of Francesco Maria Lavino as Chief Commercial Officer. // |
|
|
|
